StageIncubator/Accelerator | Alive
Genoplan is a one-spit (saliva) healthcare solution and Asian-focused biotechnology company with offices in Seoul, Tokyo, Fukuoka and Singapore. The company provides a modular B2B2C platform that you can customize to your health needs. Its end-to-end omni-channel offering tailor-made genetic testing kit, cutting-edge technology, software solution and healthy corporate care portal.
Missing: Genoplan's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Genoplan's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Genoplan
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Genoplan is included in 4 Expert Collections, including Medical Devices.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Genoplan has filed 1 patent.
The 3 most popular patent topics include:
- Computational phylogenetics
DNA, Computational phylogenetics, Molecular biology, Bioinformatics, Biotechnology
DNA, Computational phylogenetics, Molecular biology, Bioinformatics, Biotechnology
Latest Genoplan News
Jan 26, 2021
49 total views, 49 today views When it comes to newcomers, startups in the biotech industry usually drive in the numbers. South Korea isn’t an exception to this trait as technological and knowledge advancements fuel new treatment and pathogen analysis forms. Biotech companies use life forms to solve problems through technology promoting health & wellness. The two main branches of the industry are pharmaceuticals , which develop a new medication that leads to better health, and therapeutics, which analyze drug use and administration in terms of treatment. Koreatechdesk.com has compiled a list of promising Korean startups leading treatment, medicine, and therapy in 2021. 1. Sky Labs: Sky Labs is a preventative healthcare company aiming to transform conventional hospital-centric care into patient-centric care with continuous monitoring of its daily life. The startup is best known for CART, a ring-type Cardio Tracker that helps monitor atrial fibrillation (AF), which is an irregular heart rhythm that led to symptoms that negatively affect the quality of life. AF itself is not life-threatening. However, if left untreated, the side-effects of AF can be life-threatening, leading to stroke or heart failure. CART detects AF using photoplethysmography (PPG) signals, providing 99.6% accurate detecting AF, real-time monitoring, and AF analysis. It also allows you’re doctor to access the data remotely and make recommendations. SkyLabs. CART gained worldwide attention in 2019 and 2020, winning the ESC technology competition in both years, the young investigator award 2019 in the heart rhythm scientific sessions, and the young investigator award 2018 from the Korean society of cardiology. Their focus for 2021 is to expand to the European and US markets through seeking sales licenses for CART I. 2. Noom Noom is a health and wellness startup using mobile technology to help people to lead better lives. The behavior change company combines mobile technology, AI, and psychology with 1000 personal coaches’ empathy. Noom helps people live healthier lives by recommending eating plans designed by registered dietitians, giving users access to healthy food recipes, workout plans, and exercise articles. Noom Through the app, users can record their meals, get workout plans, and track their exercise progress. If you need support or motivation with your dieting program, you can quickly consult your assigned coach through the platform. The platform also has behavior change courses for diabetes prevention, which was the first of its kind to be recognized by the CDC. 3. Rokit healthcare ROKIT Healthcare is a 4D Bioprinting and Biotechnology company that develops safe and effective organ regeneration using proprietary bio-fabrication technologies. With the aid of computer motions, 4D bioprinting can precisely create living cells and biomaterials layer by layer generating structures that mimic human tissues and organs. Rokit developed Dr. INVIVO 4D2 as the first clean-chamber bioprinter to print freeform cell suspensions, hydrogels, thermoplastic filaments, pastes, and other composite materials essential for both hard and soft tissue engineering. Dr. INVIVO 4D6 supports cell fabrication and storage through its 3-dimensional space, which comes with an inbuilt cell incubator and liquid handling functions that keep the cells functional during fabrication. The startup offers anti-aging solutions such as NMN, which raises NAD+ levels and helps improve ‘aging-related’ diseases such as diabetes, brain, and cardiovascular diseases. Other anti-aging products include Aqua de Folli, which prevents hair loss, and Hi-Bikini reduces body fat. Rokit started an open innovation where it shares its regeneration technology through webinars and Youtube Live. It encourages other firms in the same sector to partner with them in continuous research and development. 4. Genome & Company Genome and company is a Seoul based startup that provides innovative genomics products, bioinformatics consulting, sequencing services, and custom research solutions. The startup has a vast clientele for its medical institution, pharmaceutical companies, academic laboratories, and government agencies. The startup does custom curation of biological databases, including disease genetics, genomics, and proteomic databases. Genome & Company Each of its projects fits the consumer’s needs and is delivered with multiple analysis tools that simplify and hasten the data analysis process. Genome and the company also provide customized bioinformatics models and strategies based on the researcher’s need to carry out genomic analysis and interpretation. The startup has secured over $10 million in funding and is planning to expand its services to the Japanese and Chinese markets in 2021 5. Exocobio Exocobio is a medical and cosmeceutical company that provides skin regeneration, inflammatory diseases treatment, anti-aging products, and tissue repair. The startup’s products focus on Exosomes, which are nano-vesicles secreted by cells for intercellular signaling. Exosomes secreted by stem cells stimulate tissue and cellular regeneration. The startup’s popular products include ASCE, Celltweet, and Exomage. Since its inception, the startup has secured over $46 million in funding, mainly from Korean VC firms such as KDB Capital, K2 Investment, and Seven Tree Equity partners. In 2021, the firm plans to increase its R&D in making GMP-compliant exosomes products and venture into the worldwide cosmetics market. According to Byong Cho, CEO of Exocobio, “We are going to step up our R&D and business so that ExoCoBio will be one of the leaders in the global exosome industry.” 6. Genoplan Genoplan is a genetic testing startup that combines cutting-edge technology and its seasoned employees’ professional expertise to change the health and wellness sector. It uses innovative technology and facilities to provide the most accurate and fastest genetic analysis results. The user only needs to purchase their affordable home saliva testing kit and send their used kit to Genoplan. Typically, the user will receive the genetic analysis results within ten business days, along with a life-long membership, research updates, and a detailed analysis of all their genetic and non-genetic factors. GENOplan These detailed results allow the user to track their inherent characteristics, including susceptibility to certain diseases and behaviors. Genoplan is Korea’s first B2C company to enter the DNA testing market. Genoplan has secured $23 million in investment from their Serie A and B funding rounds. In 2021, the startup plans to build a platform where all its customers can easily access their genetic information and take preventative measures against any genetic risk factors they may have. It also plans to expand its offices to the Chinese and European markets. 7. Bionetix Bionetix is a biotech startup specializing in creating new medical therapies to treat glaucoma, relapsed cancer, and other incurable diseases. The startup is keen on developing novel drugs that seek to inhibit or completely block the genetic processes that lead to tumor cell DNA changes, allowing them to survive in the host’s body and begin spreading. Bionetix Bionetix has a state-of-the-art R&D department that focuses on developing new enzyme inhibitors against incurable diseases that would be more effective than today’s standard treatment. It also uses study results from public research organizations to develop new medicines and subsequent clinical studies to ascertain their safety and effectiveness. It has currently collaborated with Southern Research, a British research firm, in developing novel therapeutics and epigenetic agents to fight off cancer. 8. The Wave Talk The Wave Talk is Korea’s leading bacteriological sensor startup, which develops laser sensors up to 10000 times more powerful than today’s sensor. Unlike today’s procedure for bacterial identification and analysis, which can take days, the bacteria sensor takes a few seconds to identify different bacteria species in large samples. The Wave Talk The bacteria sensor can detect low bacteria concentrations on large sample sizes through its deep learning system, which would otherwise need expensive precise equipment. The bacteria sensor is set to decrease diagnosis-related medical costs and heavily cut down on the time taken to run nano and micro-particles tests. The wave talk has secured $6 million in funding from local VC firms such as Estech Pharma, LB investments, and the D2 Startup factory. Also Read,
Genoplan Frequently Asked Questions (FAQ)
When was Genoplan founded?
Genoplan was founded in 2014.
Where is Genoplan's headquarters?
Genoplan's headquarters is located at 21 F, Kyobo Tower B, Seoul.
What is Genoplan's latest funding round?
Genoplan's latest funding round is Incubator/Accelerator.
How much did Genoplan raise?
Genoplan raised a total of $18.9M.
Who are the investors of Genoplan?
Investors of Genoplan include Startupbootcamp Scale Osaka, Mission Capital, GC Pharma, Mission Capital Advisors, DAYLI Partners and 9 more.
Who are Genoplan's competitors?
Competitors of Genoplan include 23andMe.
Compare Genoplan to Competitors
CloudSeq provides a cloud-based bioinformatics solution. The platform enables researchers to collaborate on research in Next Generation Sequencing (NGS). The three focus areas are clinical genomics, agrigenomics and metagenomics.
MyHeritage is a family history network helping families around the world discover and share their legacy online. It aims to empower its users with social tools and a library of historical content.
Ancestry offers a website offering family history information, historical records and other genealogical information. Ancestry.com offers several localized Web sites designed to empower people to discover, preserve and share family history. Ancestry has more than 2.2 million paying subscribers across its core Ancestry websites and approximately 1.5 million DNA samples in the AncestryDNA database.
FitnessGenes is a a pioneer in DNA testing and interpretation, specializing in personalized fitness and nutrition.
MedySapiens provides genetic analysis test service to global medical institutes by applying Bio-Technology and Artificial Intelligence technologies in order to save lives and improve Quality of Life for rare disease patients. The firm's products consist of MedyNA (MedySapiens’ Neonatal Action panel, yet a tentative name planned for a trademark filing soon) and MedyCVi (MedySapiens’ Cloud for Variant interpretation).
Somos creates a genetic database for Latin Americans to track ethnic origins.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.